Mind Medicine MindMed Inc
For the period ended Dec 31, 2024. Filed Mar 6, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 6, 2025
DFTX$35.39+6.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Shareholders’ Equity
(in thousands, except share amounts)
| Common Shares | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Additional Paid-In Capital | Accumulated OCI | Accumulated Deficit | Total | |
| Balance, December 31, 2022 | 37,979,136 | — | 344,758 | 627 | (194,468) | 150,917 |
| Issuance of common shares, net of share issuance costs | 2,232,113 | — | 7,823 | — | — | 7,823 |
| Exercise of 2022 USD Financing Warrants | 27,000 | — | 178 | — | — | 178 |
| Settlement of restricted share unit awards | 849,721 | — | — | — | — | — |
| Stock-based compensation expense | — | — | 15,183 | — | — | 15,183 |
| Exercise of stock options | 13,333 | — | 49 | — | — | 49 |
| Net loss and comprehensive loss | — | — | — | (284) | (95,732) | (96,016) |
| Balance, December 31, 2023 | 41,101,303 | — | 367,991 | 343 | (290,200) | 78,134 |
| Issuance of common shares and warrants, net of share issuance costs | 38,624,064 | — | 234,267 | — | — | 234,267 |
| Issuance of common shares upon settlement of restricted share unit awards, net of shares withheld for tax | 823,361 | — | (54) | — | — | (54) |
| Exchange of common shares for pre-funded warrants | (8,325,000) | — | — | — | — | — |
| Issuance of common shares upon conversion of loan principal | 748,129 | — | 3,000 | — | — | 3,000 |
| Exercise of 2022 USD Financing Warrants | 1,945,523 | — | 16,675 | — | — | 16,675 |
| Stock-based compensation expense | — | — | 16,913 | — | — | 16,913 |
| Exercise of stock options, net of options withheld for tax | 183,383 | — | 716 | — | — | 716 |
| Net loss and comprehensive loss | — | — | — | 476 | (108,679) | (108,203) |
| Balance, December 31, 2024 | 75,100,763 | $— | $639,508 | $819 | $(398,879) | $241,448 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.